ANTX
AN2 Therapeutics Inc
NASDAQ: ANTX · HEALTHCARE · BIOTECHNOLOGY
$4.68
-1.27% today
Updated 2026-04-29
Market cap
$163.78M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.16
Dividend yield
—
52W range
$1 – $7
Volume
1.7M
AN2 Therapeutics Inc (ANTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-52.10%
ROA
-30.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | — | $-33.81M | — | — | — |
| 2020 | $0.00 | $-13.60M | — | — | — |
| 2021 | $0.00 | $-21.47M | — | — | — |
| 2022 | $0.00 | $-41.47M | — | — | — |
| 2023 | $0.00 | $-64.73M | — | — | — |
| 2024 | $0.00 | $-51.32M | — | — | — |
| 2025 | $0.00 | $-35.17M | — | — | — |